Abstract:Chemodynamic therapy (CDT) is a newly developed cancer-therapeutic modality that kills cancer cells by the highly toxic hydroxyl radical (OH) generated from the in situ triggered Fenton/Fenton-like reactions in an acidic and H2O2-overproduced tumor microenvironment (TME). By taking the advantage of the TME-activated catalytic reaction, CDT enables a highly specific and minimally-invasive cancer treatment without external energy input, whose efficiency mainly depends on the reactant concentrations of both the catalytic ions and H2O2, and the reaction conditions (including pH, temperature, and amount of glutathione). Unfortunately, it suffers from unsatisfactory therapy efficiency for clinical application because of the limited activators (i.e., mild acid pH and insufficient H2O2 content) and overexpressed reducing substance in TME. Currently, various synergistic strategies have been elaborately developed to increase the CDT efficiency by regulating the TME, enhancing the catalytic efficiency of catalysts, or combining with other therapeutic modalities. To realize these strategies, the construction of diverse nanocarriers to deliver Fenton catalysts and cooperatively therapeutic agents to tumors is the key prerequisite, which is now being studied but has not been thoroughly summarized. In particular, nanocarriers that can not only serve as carriers but are also active themselves for therapy are recently attracting increasing attention because of their less risk of toxicity and metabolic burden compared to nanocarriers without therapeutic capabilities. These therapy-active nanocarriers well meet the requirements of an ideal therapy system with maximum multifunctionality but minimal components. From this new perspective, in this review, we comprehensively summarize the very recent research progress on nanocarrier-based systems for enhanced CDT and the strategies of how to integrate various Fenton agents into the nanocarriers, with particular focus on the studies of therapy-active nanocarriers for the construction of CDT catalysts, aiming to guide the design of nanosystems with less components and more functionalities for enhanced CDT. Finally, the challenges and prospects of such a burgeoning cancer-theranostic modality are outlooked to provide inspirations for the further development and clinical translation of CDT. This review summarizes the strategies to engineer CDT nanocatalysts based on diverse nanocarriers, especially those with intrinsic therapeutic activities.

Nanocatalysts-Augmented Fenton Chemical Reaction for Nanocatalytic Tumor Therapy

Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy

Nanocatalyst‐Mediated Chemodynamic Tumor Therapy

Nanocatalytic Tumor Therapy by Single-Atom Catalysts.

Novel Strategy for Optimized Nanocatalytic Tumor Therapy: From an Updated View

Development of an Intelligent Heterojunction Fenton Catalyst for Chemodynamic/starvation Synergistic Cancer Therapy

Catechol‐Isolated Atomically Dispersed Nanocatalysts for Self‐Motivated Cocatalytic Tumor Therapy

Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances

Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction

Fenton Reaction Induced by Fe-Based Nanoparticles for Tumor Therapy

A Chemodynamic Nanoenzyme with Highly Efficient Fenton Reaction for Cancer Therapy.

Back Cover: Nanomaterials for Cascade Promoted Catalytic Cancer Therapy (view 6/2021)

Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment

pH-responsive iron-loaded carbonaceous nanoparticles for chemodynamic therapy based on the Fenton reaction

Recent advances in augmenting Fenton chemistry of nanoplatforms for enhanced chemodynamic therapy

Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions

Boosting H2O2‐Guided Chemodynamic Therapy of Cancer by Enhancing Reaction Kinetics Through Versatile Biomimetic Fenton Nanocatalysts and the Second Near‐Infrared Light Irradiation

Strategies to Engineer Various Nanocarrier-Based Hybrid Catalysts for Enhanced Chemodynamic Cancer Therapy

Chemodynamic Therapy Combined with Multifunctional Nanomaterials and Their Applications in Tumor Treatment

Photothermal Therapy Nanomaterials Boosting Transformation of Fe(III) into Fe(II) in Tumor Cells for Highly Improving Chemodynamic Therapy

Nanomaterials-modulated Fenton reactions: Strategies, chemodynamic therapy and future trends